IGC Pharma
IGC
#10743
Rank
S$26.45 M
Marketcap
S$0.23
Share price
-4.61%
Change (1 day)
-48.65%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Market capitalization of IGC Pharma (IGC)

Market cap: S$26.45 Million

As of November 2026 IGC Pharma has a market cap of S$26.45 Million. This makes IGC Pharma the world's 10743th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of IGC Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026S$26.45 M-26.02%
2025S$35.75 M-8.2%
2024S$38.95 M65.21%
2023S$23.57 M4.18%
2022S$22.63 M-66.42%
2021S$67.39 M-23.67%
2020S$88.29 M162.71%
2019S$33.61 M121.95%
2018S$15.14 M-59.69%
2017S$37.56 M226.67%
2016S$11.5 M97.87%
2015S$5.81 M-51.66%
2014S$12.02 M14.34%
2013S$10.51 M6.06%
2012S$9.91 M26.4%
2011S$7.84 M-38.2%
2010S$12.69 M-49.2%
2009S$24.98 M78.51%
2008S$13.99 M-88.2%
2007S$0.11 B-5.19%
2006S$0.12 B

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of IGC Pharma was reported to be:

S$26.67 Million
by Nasdaq info icon info icon
S$26.45 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sterling Infrastructure
STRL
S$11.48 B 43,327.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
S$3.07 B 11,526.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
S$7.07 B 26,657.17%๐Ÿ‡บ๐Ÿ‡ธ USA